Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.9M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
10.1K
-
Shares change
-
0
-
Total reported value, excl. options
-
$39.1K
-
Price
-
$3.88
Significant Holders of Anixa Biosciences Inc - Common Stock (ANIX) as of Q4 2023
1 filings reported holding ANIX - Anixa Biosciences Inc - Common Stock as of Q4 2023.
Anixa Biosciences Inc - Common Stock (ANIX) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.1K shares
of 37.9M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.39M shares), UBS Group AG (581K shares), MISSION WEALTH MANAGEMENT, LP (501K shares), LAIRD NORTON TRUST COMPANY, LLC (369K shares), GEODE CAPITAL MANAGEMENT, LLC (312K shares), Long Focus Capital Management, LLC (166K shares), BlackRock Inc. (157K shares), STATE STREET CORP (109K shares), Bank of New York Mellon Corp (96.7K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (73.3K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.